CLASS II Drug recall · Reported 23 Mar 2022 · FDA Enforcement Report

Alprazolam Tablets, USP 1mg recalled by Golden State Medical Supply

Golden State Medical Supply is recalling Alprazolam Tablets, USP 1mg. The recall was initiated on 2 Mar 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: GS027852, Expiry: 06/2022.
Quantity recalled401 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0654-2022
FDA event ID
89712
Recalling firm
Golden State Medical Supply, Camarillo, CA
Classification
Class II
Status
Terminated
Recall initiated
2 Mar 2022
FDA classified
15 Mar 2022
Reported
23 Mar 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

2 Mar 2022Recall initiated by company
15 Mar 2022Classified by FDA+13 days
23 Mar 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.

Product as listed by the FDA

Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA NDC 60429-504-18.

Where it was distributed

Distributed to 1 wholesaler/distributor

Questions about this recall

Why was it recalled?

CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.

Which lots are affected?

Lot #: GS027852, Expiry: 06/2022.

Where was it sold?

Distributed to 1 wholesaler/distributor

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Golden State Medical Supply

All 55

Other Alprazolam recalls

All 23